Allograft vasculopathyChanges in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation☆
Section snippets
Patient population
The study cohort consisted of heart transplant recipients who underwent post-transplant angiography at Rush–Presbyterian–St. Luke’s Medical Center. We excluded patients <18 years of age, patients with known angiographic evidence of coronary artery stenosis exceeding 50% of luminal diameter, and patients with evidence of acute rejection in endomyocardial biopsy specimens at the time of angiography. All patients gave informed consent according to the guidelines of the Rush–Presbyterian–St. Luke’s
Patient characteristics
The mean age of the 45 study patients was 48 ± 10 years (range, 18–64 years), and the mean donor age was 28 ± 13 years (range, 11–55 years). Forty-one were men, and 4 were women. The pre-transplant diagnosis was coronary artery disease in 21 (47%) and non-ischemic cardiomyopathy in 24 (53%). All patients received triple-immunosuppressive therapy (prednisone, cyclosporine, and azathioprine or mycophenolate mofetil) and pravastatin. Calcium-channel antagonists were not prescribed routinely to
Discussion
It stands to reason that the vascular endothelium would be involved in initiating chronic rejection after cardiac transplantation, because it is situated between circulating immune cells and the vessel wall. Endothelial damage leads to intimal proliferation, macrophage migration, and eventual smooth muscle hyperplasia.15 Other risk factors recognized to promote allograft vasculopathy, such as hyperlipidemia, hypertension, and hyperglycemia, also cause endothelial dysfunction, in part through
Conclusions
We performed serial studies using simultaneous IVUS and Doppler measurements to assess epicardial and microvascular endothelial function in heart transplant recipients. The study is the first to show that patients with cardiovascular end-points after heart transplantation had a more rapid decrease in endothelial function than did patients without end-points. These data implicate endothelial dysfunction in the development of clinically significant vasculopathy and suggest that serial studies of
References (29)
- et al.
The Registry of the International Society for Heart and Lung Transplantationsixteenth official report—1999
J Heart Lung Transplant
(1999) Endothelial dysfunctionclinical implications
Prog Cardiovasc Dis
(1997)- et al.
Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound
J Am Coll Cardiol
(1995) - et al.
Intravascular ultrasound imaging after cardiac transplantationadvantage of multi-vessel imaging
J Heart Lung Transplant
(2000) - et al.
Endothelial dysfunction in the development and detection of transplant coronary artery disease
J Heart Lung Transplant
(1992) - et al.
Cardiac allograft vasculopathya review
Circulation
(1997) Allograft vasculopathydiagnosing the nemesis of heart transplantation
Circulation
(1999)- et al.
Heart transplant coronary artery disease detected by coronary angiographya multi-institutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database
J Heart Lung Transplant
(1998) - et al.
Incidence and progression of transplant coronary artery disease over 1 yearresults of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group
J Heart Lung Transplant
(1995) - et al.
Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation
J Heart Lung Transplant
(1998)
Simultaneous intracoronary ultrasound and Doppler flow studies distinguish flow-mediated from receptor-mediated endothelial responses
Catheter Cardiovasc Interv
Effects of adenosine on human coronary arterial circulation
Circulation
Responses of coronary arteries of cardiac transplant patients to acetylcholine
J Clin Invest
Endothelial dysfunction early after heart transplantation
Circulation
Cited by (0)
- ☆
This work was supported in part by a grant-in-aid from the Metropolitan Chicago American Heart Association and in part by a SmithKline Beecham Junior Faculty Development Award to Dr. Hollenberg.